Goldman Ismail Secures Complete Defense Jury Verdict in Pelvic Mesh Trial
On January 21, 2020, a federal jury rejected plaintiffs’ claims related to the Artisyn pelvic mesh device. Artisyn is manufactured by Ethicon, Inc., a subsidiary of Johnson & Johnson.
The plaintiffs, a woman implanted with Artisyn and her husband, alleged that she suffered permanent injuries from this device, including a fistula, a series of small bowel obstructions, pelvic pain, painful intercourse, and an incisional hernia. In closing argument, the plaintiffs requested approximately $35 million in compensatory damages and also sought punitive damages. The Court had previously granted Ethicon’s motion for summary judgment on plaintiffs’ failure to warn claim.
After a two-week trial, the jury deliberated for approximately five hours before returning a full defense verdict.
The trial team was led by Shayna Cook of Goldman Ismail, Paul Cassisa of Butler Snow, and Andy Kruppa of Squire Patton Boggs. Betsy Farrington from Goldman Ismail also assisted. The case is Salinero et al. v. Johnson & Johnson et al., case number 1:18-cv-23643, in the U.S. District Court for the Southern District of Florida. Press coverage of the trial win is available here.